Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674532 | SCV000799884 | uncertain significance | Hyperinsulinemic hypoglycemia, familial, 1 | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002477510 | SCV002787390 | uncertain significance | Diabetes mellitus, transient neonatal, 2; Hyperinsulinemic hypoglycemia, familial, 1; Leucine-induced hypoglycemia; Type 2 diabetes mellitus; Diabetes mellitus, permanent neonatal 3 | 2022-04-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002531354 | SCV003440274 | likely pathogenic | not provided | 2024-01-11 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 16 of the ABCC8 gene. It does not directly change the encoded amino acid sequence of the ABCC8 protein. This variant is present in population databases (rs377174421, gnomAD 0.0009%). This variant has been observed in individual(s) with autosomal recessive familial hyperinsulinism (PMID: 28442472). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 558288). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |